In 2019, when Dennis Slamon, Axel Ullrich, and Michael Shepard received the Lasker-DeBakey Clinical Medical Research Award, the New England Journal of Medicine published an article by the former American Society of Clinical Oncology (ASCO) president Daniel Hayes, entitled ‘HER2 and Breast Cancer - A Phenomenal Success Story’ (1). The gene discussed is ERBB2; the disease is breast carcinoma.